| Literature DB >> 19745033 |
Yong-Jun Li1, Lia Danelishvili1, Dirk Wagner2, Mary Petrofsky3, Luiz E Bermudez4,1.
Abstract
Mycobacterium avium is an opportunistic pathogen associated with pulmonary disease in non-AIDS patients and disseminated infection in patients with AIDS. The chief route of infection is by colonization and invasion of the mucosa of the gastrointestinal tract, but infection through the respiratory route also occurs. After crossing the mucosa, M. avium infects and replicates within tissue macrophages. To identify M. avium genes required for survival in vivo, a library of signature-tagged transposon mutants was constructed and screened for clones attenuated in mice. Thirty-two clones were found to be attenuated for their virulence, from which eleven were sequenced and tested further. All the mutants studied grew similarly in vitro to the wild-type MAC104. Ten mutants were tested individually in mice, confirming the attenuated phenotype. MAV_2450, a polyketide synthase homologue to Mycobacterium tuberculosis pks12, was identified. STM5 and STM10 genes (encoding two hypothetical proteins MAV_4292 and MAV_4012) were associated with susceptibility to oxidative products. Mutants MAV_2450, MAV_4292, MAV_0385 and MAV_4264 live in macrophage vacuoles with acidic pH (below 6.9). Mutants MAV_4292, MAV_0385 and MAV_4264 were susceptible to nitric oxide in vitro. The study of individual mutants can potentially lead to new knowledge about M. avium pathogenic mechanisms.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19745033 PMCID: PMC2887559 DOI: 10.1099/jmm.0.012864-0
Source DB: PubMed Journal: J Med Microbiol ISSN: 0022-2615 Impact factor: 2.472
Fig. 1.Schematic representation of the approach used. The pYJTags was created from pUC19 with the insertion of a temperature-sensitive (ts) Myc ori. It allowed for the integration of the transposon once the environmental temperature was elevated to 41 °C.
Genes inactivated in the identified mutants
Attenuated mutants were identified by screening an STM library. The mutants were tested individually for attenuation.
| STM1/STM7 | MAV_2450 | Polyketide synthase 12 |
| STM2 | MAV_3321 | ABC transporter, ATP-binding subunit |
| STM3 | MAV_3105 | Polyketide synthase 11 |
| STM4 | MAV_2723 | PAP A2 condensation domain |
| STM5 | MAV_4292 | Hypothetical protein |
| STM6 | MAV_0385 | |
| STM8 | MAV_1346 | PE family protein |
| STM9 | MAV_4366 | Chaperonin GroES |
| STM10 | MAV_4012 | Conserved hypothetical protein |
| STM11 | MAV_4264 | Hypothetical protein, homology with bacterial regulatory protein TetR domain |
Comparison of the number of organisms in the WT strain MAC 104 and the other STM clones at several time points following infection of mice
C57BL/6 mice were infected intravenously and their spleens were harvested at 24 h, and at weeks 1, 3 and 5, for quantification of the bacterial load.
| STM1 | 6.7±0.3×106 | 6.7±0.4×106 | 6.1±0.4×105* | 5.2±0.3×104* |
| STM2 | 6.1±0.3×106 | 6.5±0.4×106 | 6.0±0.2×106 | 4.9±0.2×103* |
| STM3 | 5.5±0.5×106 | 2.3±0.2×106 | 1.2±0.1×106* | 8.6±0.4×105* |
| STM4 | 5.6±0.4×106 | 3.2±0.3×106 | 2.0±0.2×106* | 1.4±0.3×106* |
| STM5 | 3.8±0.2×106 | 1.1±0.2×106* | 1.5±0.1×106 | 9.4±0.7×105* |
| STM6 | 2.3±0.9×106 | 1.1±0.7×106* | 8.3±0.6×105* | 8.1±0.5×105* |
| STM8 | 1.6±0.2×106 | 1.8±0.6×106* | 1.8±0.4×106 | 1.9±0.3×105* |
| STM10 | 3.2±0.4×106 | 1.1±0.3×106* | 2.0±0.4×106 | 7.3±0.3×104* |
| STM11 | 5.1±0.3×106 | 2.7±0.4×106 | 8.5±0.3×105* | 5.3±0.6×104* |
| WT (MAC 104) | 1.9±0.2×106 | 3.8±0.2×106 | 1.3±0.2×107 | 4.6±0.4×107 |
*P<0.05 compared with the WT MAC 104 at the same time point.
Susceptibility of M. avium attenuated clones to superoxide anion
| WT (MAC 104) | 2.1±0.3×105 | 3.3±0.5×105 | 2.1±0.4×105 |
| STM1 | 3.6±0.4×105 | 1.1±0.3×105 | 1.5±0.2×105 |
| STM2 | 2.7±0.3×105 | 9.0±0.2×104 | 8.6±0.3×104 |
| STM3 | 5.1±0.5×105 | 3.0±0.2×105 | 2.6±0.4×105 |
| STM4 | 2.3±0.4×105 | 2.0±0.5×105 | 1.8±0.3×105 |
| STM5 | 3.0±0.5×105 | 8.2±0.4×104 | 2.0±0.5×105† |
| STM6 | 3.9±0.2×105 | 1.9±0.3×105 | 1.6±0.4×105 |
| STM8 | 3.6±0.5×105 | 8.1±0.2×104 | 7.6±0.4×104 |
| STM10 | 3.7±0.3×105 | 8.5±0.4×104 | 1.0±0.3×105† |
| STM11 | 4.7±0.3×105 | 8.1±0.6×104 | 8.5±0.2×104 |
*RAW 246.7 macrophage monolayers were infected with M. avium for 1 h and extracellular bacteria were removed by washing. Some wells were incubated with 2 mg SOD ml−1, as reported in Methods. Monolayers were lysed at 24 h and viable intracellular bacteria quantified. The experiment was repeated three times.
†P<0.05 compared with the number of c.f.u. (ml macrophage lysate)−1 at 24 h without adding SOD.
Susceptibility of M. avium clones to the effect of nitric oxide
| WT (MAC 104) | 6.4±0.3×105 | 8.3±0.3×105 | 8.7±0.5×105 |
| STM1 | 2.0±0.4×105 | 8.1±0.3×104 | 8.5±0.6×104 |
| STM2 | 4.4±0.2×105 | 7.6±0.3×104 | 8.1±0.2×104 |
| STM3 | 5.2±0.5×105 | 4.1±0.3×105 | 3.8±0.4×105 |
| STM4 | 2.6±0.2×105 | 1.0±0.3×105 | 9.8±0.2×105 |
| STM5 | 3.4±0.2×105 | 9.8±0.3×104 | 1.0±0.4×105 |
| STM6 | 3.9±0.5×105 | 2.8±0.4×105 | 2.7±0.6×105 |
| STM8 | 3.8±0.2×105 | 8.3±0.3×104 | 7.6±0.5×104 |
| STM10 | 4.6±0.3×105 | 4.1±0.5×104 | 1.6±0.3×105† |
| STM11 | 2.5±0.5×105 | 7.8±0.4×104 | 1.2±0.6×105† |
*RAW 246.7 macrophage monolayers were infected for 1 h with M. avium, washed, and all of the wells were treated with IFN-γ and with 100 μM N-methylarginine. The monolayers were lysed after 24 h and the intracellular bacteria quantified. The experiments were repeated three times.
†P<0.05 compared with the number of bacteria at 24 h without N-methylarginine.
Vacuole pH of RAW 264.7 macrophages
| WT (MAC 104) | 6.4 | 6.9 |
| STM1 | 5.3* | 5.6* |
| STM5 | 5.5* | 5.7* |
| STM6 | 5.7* | 6.5* |
| STM10 | 5.2* | 5.1* |
| STM11 | 4.8* | 4.5* |
*P<0.05 compared with the WT MAC 104. Experiments were repeated three times.
Ability of complemented strains STM1 comp, STM5 comp, STM8 comp, STM10 comp and STM11 comp to replicate in murine macrophages
Assays were repeated three times. The numbers represent means±sd.
| WT MAC 104 | 2.3±0.3×105 | 7.1±0.2×105 |
| SMT1 | 2.7±0.4×105 | 7.0±0.4×104* |
| STM1 comp | 2.1±0.5×105 | 6.7±0.4×105† |
| STM5 | 3.8±0.4×105 | 1.6±0.3×104* |
| STM5 comp | 2.5±0.6×105 | 5.9±0.5×105† |
| STM8 | 5.0±0.4×105 | 6.7±0.3×104* |
| STM8 comp | 4.1±0.3×105 | 6.9±0.4×105† |
| STM10 | 2.8±0.2×105 | 9.8±0.6×103* |
| STM10 comp | 3.4±0.4×105 | 4.1±0.5×105† |
| STM11 | 3.0±0.3×105 | 6.1±0.3×103* |
| STM11 comp | 4.4±0.5×105 | 9.5±0.4×104† |
*P<0.05 compared with the WT MAC 104 at day 4.
†P<0.05 compared with the mutated strain at day 4.